This recent article in DarkDaily emphasizes the relationships, technological advancements, and direction that companies like ours are spearheading. https://lnkd.in/eqNJVYYm
Gestalt
Medical and Diagnostic Laboratories
Spokane, WA 1,338 followers
Transforming Pathology Labs with AI-Powered Digital Pathology
About us
Gestalt transforms pathology through an intelligent, configurable, and vendor-neutral, AI-driven, digital workflow that provides true interoperability enabling pathologists to diagnose* diseases faster and more efficiently. Our PathFlow® solution is a cloud-based digital pathology enterprise platform that can easily be customized based on your specific preferences. This platform consists of professional, education, and research modules for ease of mixing and matching the digital needs of your facility in a single solution, freeing pathologists from tedious, repetitive, and manual tasks allowing them to focus on their expertise, providing their invaluable experience where it matters most. *Research Use Only (RUO) unless following CAP guidelines for LDT.
- Website
-
http://www.gestaltdiagnostics.com
External link for Gestalt
- Industry
- Medical and Diagnostic Laboratories
- Company size
- 11-50 employees
- Headquarters
- Spokane, WA
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Digital Pathology, Laboratory, Anatomic Pathology, Secondary Diagnosis, Peer Review, Clinical Trials, Telepathology, Cloud-based, SaaS, Validation and QA, Oncology, Digital Storage, Universal Viewer, Integration, Digital Workflow, Integrated Delivery Network, Interoperability, Interfaces, Artificial Intelligence Algorithms, and IT Staff Augmentation
Locations
-
Primary
850 E. Spokane Falls Blvd.
Spokane, WA 99202, US
Employees at Gestalt
Updates
-
We are excited to be chosen by DataPathology to support their 5 laboratories in Africa with our digital pathology solutions. This ensures patient access to pathology services in an under served population. https://lnkd.in/eQ9NNMyw
Gestalt Expands Internationally with First Client in Africa: DataPathology
gestaltdiagnostics.com
-
Check out this article to learn why Gestalt is a market leader in digital pathology! If you are attending the DP- AI Workshop Sessions this week at Mackenzie Health in Toronto stop by our booth!
Great article by The Dark Report, and thank you for the call out for one of our differentiators. "One interesting observation is that the only company listed in all three functional categories is Gestalt Diagnostics. This must be a market-winning business strategy for Gestalt Diagnostics, as it is the only digital pathology company on the list above to grow rapidly enough to have made Inc. Magazine’s 2023 “5000 Fastest Growing Private Companies in America.” You can read the full article, entitled 'Uncertainty in Pathology Market for Digital Products and AI Solutions' #thedarkreport, #digitalpathology, #Gestalt
-
Great article by The Dark Report, and thank you for the call out for one of our differentiators. "One interesting observation is that the only company listed in all three functional categories is Gestalt Diagnostics. This must be a market-winning business strategy for Gestalt Diagnostics, as it is the only digital pathology company on the list above to grow rapidly enough to have made Inc. Magazine’s 2023 “5000 Fastest Growing Private Companies in America.” You can read the full article, entitled 'Uncertainty in Pathology Market for Digital Products and AI Solutions' #thedarkreport, #digitalpathology, #Gestalt
-
Gestalt VP, AI Innovation to Co-Lead the DICOM working group 26. https://lnkd.in/eRPnRkK3
-
Our Chief Strategy Officer's latest article, published in MLO, addresses the issue of preparedness for digital deployments. https://lnkd.in/eHegBChU
Prepare your lab's automation for digital pathology integration
gestaltdiagnostics.com
-
Interesting read from yesterday's news: https://lnkd.in/eAiKYVSp
House committee tells FDA to suspend lab developed test rule
healthcaredive.com
-
Gestalt's COO | CSO's latest article on biomarkers in a cancer diagnosis is in the July issue of MLO - you can read it here: https://lnkd.in/ebwSiK5C
The role of biomarkers in a prostate cancer diagnosis
mlo-online.com